Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

MT-MMP-4 Inhibitors

MT-MMP-4 inhibitors is a class of chemical compounds designed to modulate the activity of membrane-type matrix metalloproteinase 4 (MT-MMP-4), also known as MMP-17. MT-MMP-4 is a member of the matrix metalloproteinase (MMP) family, which plays a pivotal role in remodeling the extracellular matrix, a complex network of proteins that provides structural support to cells and tissues. These inhibitors are developed with the aim of interfering with the proteolytic function of MT-MMP-4, which is involved in processes such as tissue remodeling, cell migration, and angiogenesis. Chemically, MT-MMP-4 inhibitors span a diverse range of structures and functional groups. They are carefully designed to interact with the active site of the enzyme, disrupting its ability to degrade specific extracellular matrix components. These inhibitors can be classified into various chemical classes, such as hydroxamates, tetracyclines, and synthetic peptides, based on their core structures and mechanisms of interaction. The development of MT-MMP-4 inhibitors demands a deep understanding of the enzyme's structure, substrate specificity, and catalytic mechanism, as well as the use of computational tools for rational drug design. Researchers employ a variety of techniques to identify and optimize MT-MMP-4 inhibitors. High-throughput screening of compound libraries, molecular docking studies, and structure-activity relationship analyses contribute to the discovery and refinement of inhibitor candidates. The goal is to create compounds that specifically target MT-MMP-4, while minimizing unintended effects on other MMP family members or cellular processes. The field of MT-MMP-4 inhibitor development necessitates a multidisciplinary approach, integrating expertise in chemistry, biochemistry, molecular biology, and structural biology. By advancing our understanding of the complex interplay between MMPs and the extracellular matrix, these inhibitors can uncover new insights into cellular behavior and contribute to elucidating the broader implications of MMP-mediated processes in health.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

GM 6001

142880-36-2sc-203979
sc-203979A
1 mg
5 mg
$75.00
$265.00
55
(1)

Ilomastat, also known as GM6001, is a hydroxamate-based inhibitor that chelates the zinc ion in the active site of MT-MMP 4, thus directly inhibiting its enzymatic function.

Prinomastat

192329-42-3sc-507449
5 mg
$190.00
(0)

Prinomastat is an MMP inhibitor that targets the active site of MT-MMP 4, directly inhibiting its enzyme activity involved in matrix degradation.

PD166793

199850-67-4sc-202709
5 mg
$147.00
6
(1)

PD166793 is a broad-spectrum MMP inhibitor that by impeding the catalytic activity of MT-MMP 4, inhibits its ability to process and remodel the extracellular matrix.

WAY 170523

307002-73-9sc-361402
sc-361402A
1 mg
10 mg
$275.00
$595.00
1
(0)

WAY-170523 is a selective inhibitor of MMP-13 but can also inhibit MT-MMP 4 by binding to its zinc-dependent active site, which is crucial for its enzymatic activity.

UK 356618

230961-08-7sc-361392
sc-361392A
5 mg
25 mg
$115.00
$435.00
2
(0)

UK-356618 is an MMP inhibitor with the capacity to inhibit MT-MMP 4 by binding to its active site, thus preventing the protein from interacting with and degrading its substrates in the extracellular matrix.